Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Total Debt: 2020-2024

Historic Total Debt for Bicycle Therapeutics (BCYC) over the last 3 years, with Jun 2024 value amounting to $30.9 million.

  • Bicycle Therapeutics' Total Debt rose 1.30% to $30.9 million in Q2 2024 from the same period last year, while for Jun 2024 it was $30.9 million, marking a year-over-year increase of 1.30%. This contributed to the annual value of $30.7 million for FY2023, which is 1.26% up from last year.
  • Bicycle Therapeutics' Total Debt amounted to $30.9 million in Q2 2024, which was up 0.35% from $30.8 million recorded in Q1 2024.
  • Bicycle Therapeutics' Total Debt's 5-year high stood at $30.9 million during Q2 2024, with a 5-year trough of $14.4 million in Q3 2020.
  • Moreover, its 3-year median value for Total Debt was $30.5 million (2023), whereas its average is $30.5 million.
  • Data for Bicycle Therapeutics' Total Debt shows a peak YoY surged of 106.23% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Bicycle Therapeutics' Total Debt stood at $14.5 million in 2020, then spiked by 105.95% to $29.9 million in 2021, then rose by 1.48% to $30.3 million in 2022, then increased by 1.26% to $30.7 million in 2023, then increased by 1.30% to $30.9 million in 2024.
  • Its Total Debt was $30.9 million in Q2 2024, compared to $30.8 million in Q1 2024 and $30.7 million in Q4 2023.